Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank86
3Y CAGR+73.1%
5Y CAGR+24.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+73.1%/yr
vs +114.6%/yr prior
5Y CAGR
+24.3%/yr
Recent acceleration
Acceleration
-41.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $893.37M | +105.2% |
| 2024 | $435.45M | +258.0% |
| 2023 | $121.63M | -29.3% |
| 2022 | $172.15M | -14.3% |
| 2021 | $200.82M | -33.2% |
| 2020 | $300.85M | +1956.1% |
| 2019 | $14.63M | +80.1% |
| 2018 | $8.12M | -97.8% |
| 2017 | $365.00M | -79.4% |
| 2016 | $1.78B | - |